Labcorp Holdings Inc.

BOVESPA:L1CA34 Stock Report

Market Cap: R$116.3b

Labcorp Holdings Past Earnings Performance

Past criteria checks 0/6

Labcorp Holdings's earnings have been declining at an average annual rate of -12%, while the Healthcare industry saw earnings growing at 21.6% annually. Revenues have been declining at an average rate of 0.6% per year. Labcorp Holdings's return on equity is 5.3%, and it has net margins of 3.4%.

Key information

-12.0%

Earnings growth rate

-10.2%

EPS growth rate

Healthcare Industry Growth11.6%
Revenue growth rate-0.6%
Return on equity5.3%
Net Margin3.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Labcorp Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BOVESPA:L1CA34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2412,7134362,1790
30 Jun 2412,4884502,1360
31 Mar 2412,3003992,0840
31 Dec 2312,1623792,0320
30 Sep 2312,0585831,9440
30 Jun 2311,8686771,8720
31 Mar 2311,7577891,7980
31 Dec 2211,8641,0021,7630
30 Sep 2212,9901,5181,8510
30 Jun 2214,1861,8291,9180
31 Mar 2215,1042,0281,9440
31 Dec 2113,1362,1951,6900
30 Sep 2116,5552,7631,8940
30 Jun 2116,3882,8791,7870
31 Mar 2115,3162,6431,7180
31 Dec 2013,9791,5561,7290
30 Sep 2012,4428451,5500
30 Jun 2011,4753621,5350
31 Mar 2011,5873211,5230
31 Dec 1911,5558241,6250
30 Sep 1911,3897551,5210
30 Jun 1911,2928531,4960
31 Mar 1911,2768961,4900
31 Dec 1811,3338841,5780
30 Sep 1811,2911,4141,5040
30 Jun 1811,0811,2661,4830
31 Mar 1810,7431,2171,4580
31 Dec 1710,3081,2271,4990
30 Sep 179,9517241,4360
30 Jun 179,7027321,4710
31 Mar 179,5567511,5220
31 Dec 169,5537121,3060
30 Sep 169,2956581,5920
30 Jun 169,1926331,6520
31 Mar 169,0295991,5560
31 Dec 158,5064381,4690
30 Sep 157,7744471,3600
30 Jun 157,0564301,2130
31 Mar 156,3534011,2040
31 Dec 146,0125111,1810
30 Sep 145,9365181,1640
30 Jun 145,8465291,1430
31 Mar 145,7985401,1310
31 Dec 135,8085741,1290

Quality Earnings: L1CA34 has a large one-off loss of $477.1M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: L1CA34's current net profit margins (3.4%) are lower than last year (4.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: L1CA34's earnings have declined by 12% per year over the past 5 years.

Accelerating Growth: L1CA34's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: L1CA34 had negative earnings growth (-25.3%) over the past year, making it difficult to compare to the Healthcare industry average (64.3%).

Return on Equity

High ROE: L1CA34's Return on Equity (5.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 21:01
End of Day Share Price 2024/09/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Labcorp Holdings Inc. is covered by 48 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Brian Kemp DolliverAvondale Partners
Eric ColdwellBaird